KRAS and colorectal carcinoma: In CRC, it has been shown that Bromelain, a mixture of proteolytic enzymes used to treat other pathologies, simulates ferroptosis in KRAS-mutated CRC, being cytotoxic for KRAS-mutated cells but not for KRAS-WT [187].